BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 31257355)

  • 1. Generic selection criteria for safety and patient benefit [VIII]: Comparing the physicochemical and pharmaceutical properties of brand-name and generic diclofenac sodium tapes.
    Nozawa M; Goto M; Wada Y; Yotsukura K; Gannichida A; Ishii F; Shimokawa KI
    Drug Discov Ther; 2019 Jul; 13(3):150-156. PubMed ID: 31257355
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Generic selection criteria for safety and patient benefit [XI]: Usability scores of brand-name and generic tapes containing sodium diclofenac by questionnaire survey.
    Nozawa M; Gannichida A; Wada Y; Kumazawa M; Ishii F; Shimokawa KI
    Drug Discov Ther; 2022 Nov; 16(5):210-216. PubMed ID: 36261340
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Generic Selection Criteria for Safety and Patient Benefit [IV] - Physicochemical and pharmaceutical properties of brand-name and generic ketoprofen tapes.
    Wada Y; Kihara M; Nozawa M; Shimokawa K; Ishii F
    Drug Discov Ther; 2015 Jun; 9(3):229-33. PubMed ID: 26193946
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Generic selection criteria for safety and patient benefit [VI]: Comparing the physicochemical and pharmaceutical properties of brand-name, generic, and OTC felbinac tapes.
    Wada Y; Takaoka Y; Nozawa M; Goto M; Shimokawa KI; Ishii F
    Drug Discov Ther; 2017 Jan; 10(6):300-306. PubMed ID: 27725574
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Generic selection criteria for safety and patient benefit [X]: Water-vapor permeability and peel force properties of brand-name and generic ketoprofen tapes.
    Nozawa M; Goto M; Wada Y; Ishii F; Shimokawa KI
    Drug Discov Ther; 2021 May; 15(2):87-92. PubMed ID: 33952778
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Generic selection criteria for safety and patient benefit [Ⅻ]: Comparing the physicochemical and pharmaceutical properties of brand-name and generic tulobuterol tape.
    Shimokawa KI; Yotsukura K; Nozawa M; Wada Y; Ishii F
    Drug Discov Ther; 2024 Jan; 17(6):409-414. PubMed ID: 38044119
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Generic selection criteria for safety and patient benefit [VII]: Comparing the physicochemical and pharmaceutical properties of brand-name and generic terbinafine hydrochloride cream.
    Nozawa M; Goto M; Wada Y; Kumazawa M; Shimokawa KI; Ishii F
    Drug Discov Ther; 2018 Mar; 12(1):16-20. PubMed ID: 29479048
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Criteria for the selection of switch OTC drugs based on patient benefits, efficacy, and safety [II]: Comparing the physicochemical and pharmaceutical properties of brand-name and switch OTC terbinafine hydrochloride cream.
    Takata M; Wada Y; Iwasawa Y; Kumazawa M; Shimokawa KI; Ishii F
    Drug Discov Ther; 2018; 12(4):248-253. PubMed ID: 30224597
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Prediction of systemic exposure of ketoprofen tapes by in vitro release test and pharmacokinetic model analysis: comparison between brand-name and generic formulations].
    Awa K; Satoh H; Hori S; Sawada Y
    Yakugaku Zasshi; 2012; 132(1):135-44. PubMed ID: 22214588
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Questionnaire survey on the change of asthmatic response, adverse events and product usability due to drug switching between name-brand and generic tulobuterol tapes].
    Izumi T; Hori S; Satoh H; Miki A; Sawada Y
    Yakugaku Zasshi; 2012; 132(5):617-27. PubMed ID: 22687698
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Questionnaire survey of patients comparing the usability of brand-name and generic ketoprofen tapes].
    Saita A; Inoue A; Ishibashi H; Tominaga K; Hori S; Miki A; Ohtani H; Ono N; Sawada Y
    Yakugaku Zasshi; 2008 May; 128(5):795-803. PubMed ID: 18451628
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The bioequivalence and therapeutic efficacy of generic versus brand-name psychoactive drugs.
    Borgheini G
    Clin Ther; 2003 Jun; 25(6):1578-92. PubMed ID: 12860486
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of compromised skin barrier on delivery of diclofenac sodium from brand and generic formulations via microneedles and iontophoresis.
    Dandekar AA; Kale M; Garimella HT; Banga AK
    Int J Pharm; 2022 Nov; 628():122271. PubMed ID: 36220591
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Generic selection criteria for safety and patient benefit [V]: Comparing the pharmaceutical properties and patient usability of original and generic nasal spray containing ketotifen fumarate.
    Wada Y; Ami S; Nozawa M; Goto M; Shimokawa K; Ishii F
    Drug Discov Ther; 2016; 10(2):88-92. PubMed ID: 27210891
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intrapatient variation in antiepileptic drug plasma concentration after generic substitution vs stable brand-name drug regimens.
    Contin M; Alberghini L; Candela C; Benini G; Riva R
    Epilepsy Res; 2016 May; 122():79-83. PubMed ID: 26987080
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Investigation of Bioequivalence Between Brand-name and Generic Irinotecan Products.
    Saito KI; Inoue Y; Ikegami Y; Nanbo I; Onozuka M; Sano K; Yoshida H; Sakamoto T; Tatebayashi E; Fujita KI; Sasaki Y; Kitazawa T
    Anticancer Res; 2016 Nov; 36(11):5957-5963. PubMed ID: 27793921
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Generic selection criteria for safety and patient benefit [IX]: Evaluation of "feeling of use" of sodium hyaluronate eye drops using the Haptic Skill Logger (HapLog
    Goto M; Nozawa M; Wada Y; Shimokawa KI; Ishii F
    Drug Discov Ther; 2020; 14(1):14-20. PubMed ID: 32147626
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Effect of Adhesives on the Properties of Adhesion, Drug Release and Skin Permeation of Lidocaine Tapes].
    Sugino M; Mikami M; Ishihara T; Hosoya O; Juni K
    Yakugaku Zasshi; 2015; 135(8):977-85. PubMed ID: 26234356
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bioequivalence and in vitro antimicrobial activity between generic and brand-name levofloxacin.
    Sun HY; Liao HW; Sheng MH; Tai HM; Kuo CH; Sheng WH
    Diagn Microbiol Infect Dis; 2016 Jul; 85(3):347-351. PubMed ID: 27181716
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical equivalence of generic and brand-name drugs used in cardiovascular disease: a systematic review and meta-analysis.
    Kesselheim AS; Misono AS; Lee JL; Stedman MR; Brookhart MA; Choudhry NK; Shrank WH
    JAMA; 2008 Dec; 300(21):2514-26. PubMed ID: 19050195
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.